Jose Luis Guinot, Patricia Diezhandino, Jesus Maria de Frutos, Naiara Fuentemilla, Victor Gonzalez-Perez, Cristina Gutierrez, Antonio Herreros, Rafael Martinez-Monge, Susana Perez-Echagüen, Francisco Pino, Susana Roldán, Angels Rovirosa, Miguel Angel Santos, Camilo Jose Sanz-Freire, Elena Villafranca
PURPOSE: Brachytherapy (BT) has been used for many years for disease control in tumours of the head and neck area (H&N). It is currently performed with high dose rate (HDR) or pulsed dose rate (PDR), but its use has been reduced due to the implementation of new non-invasive external beam radiotherapy techniques such as intensity modulation (IMRT) and volumetric modulated arc therapy (VMAT) and the improvement of surgical techniques. METHODS: The Spanish Brachytherapy Group (GEB) has carried out a survey to find out the number of centres in Spain that continue to use BT in H&N and its indications and expectations for the future...
August 7, 2023: Clinical & Translational Oncology